[1] |
YU Hongli, YU Dongmei, XIAO Aili, ZHU Lan, SONG Haibo.
Risks of safety Qingkailing oral preparation
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1046-1048.
|
[2] |
ZHOU Yuanhua, WU Liangyong, ZHANG Liwen, DONG Shunling, YAO Shangchen, XU Mingzhe, ZHANG Xianhua.
Determination of bactericidal sodium benzoate and potassium sorbate in pediatric oral liquid preparations by HPLC
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 365-369.
|
[3] |
LI Ning, JIANG Xiaoya, ZHANG Zezhao, GAO Le, WANG Xinguo, LIU Xiaoming.
Preparation and quality evaluation of standard decoctions of Rosa chinensis Jacq.
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 397-402.
|
[4] |
WANG Yadan, YAN Jiangong, CHEN Minghui, PANG Yu, DAI Zhong, MA Shuangcheng.
UPLC fingerprints of tripterygium glycosides tablets from different manufacturers
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(2): 146-151.
|
[5] |
WANG Zhao, LIU Yue, ZAN Ke, LI Hailiang, JIN Hongyu, MA Shuangcheng.
Preliminary study on extraction technology of tea extract used for Xinnaojian preparation
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1362-1367.
|
[6] |
LIU Kecheng, WEI Tanjun, CHEN Fei, XIAO Cheng, ZHANG Yinsu.
Quality evaluation of Chaihu Shugan granules ria multi-component quantification combined with GRA and EW-TOPSIS method
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1243-1248.
|
[7] |
YANG Liandi.
One case of anaphylactic shock caused by risedronate sodium tablets
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(7): 795-798.
|
[8] |
LYU Jintao, ZHANG Xiaomeng, ZHANG Bing, JIANG Hao, LIN Zhijian.
Chinese medicine pharmacovigilance and pharmaceutical care for progestational, pregnant and post-partum women based on ancient literature
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(6): 585-590.
|
[9] |
FENG Chengyang, ZHAO Li, LIU Dong.
385 cases of adverse drug reactions/adverse drug events caused by Yinzhihuang preparations
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(3): 325-327.
|
[10] |
WANG Ying, GU Donglin, FAN Jing, YANG Jianbo, LIU Yue, WANG Xueting, WANG Qi, JIN Hongyu, WEI Feng, MA Shuangcheng.
Changes of content of 5-HMF and stilbene glycoside in Polygoni Multiflori Radix during nine-time repeat of steaming and sun-drying
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(12): 1291-1294.
|
[11] |
CAI Lele, ZHANG Zhuolin, LI Xin, FANG Danjun, HAN Feng.
Research progress in safety and effectiveness of medication of iron deficiency anemia
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(11): 1262-1265.
|
[12] |
MA Zhaozhao, WANG Qian, GAO Le, ZHEN Yaqin, WANG Xinguo, NIU Liying, ZHANG Liyan.
Study on Applicability of QAMS to Multi-component Content Determination of Citri Reticulatae Semen
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(7): 637-640.
|
[13] |
YU Yi, HUANG Qianqian, XIAO Aili.
Analysis of Safety Risks of Ginkgo Biloba Tablets and Other Oral Preparations
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(7): 678-682.
|
[14] |
YU Hongli, YU Dongmei, PANG Yu, SHAO Bo, SONG Haibo.
Risks of Shuanghuanglian Oral Preparation
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(7): 683-685.
|
[15] |
JIANG Hao, ZHANG Zhiqi, ZHANG Bing, ZHANG Xiaomeng, GENG Kexin.
Benefit-Risk Assessment of Mylabris Preparations in the Treatment of Primary Hepatic Carcinoma
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(6): 525-531.
|